NCT06888024 Pelvic Vein Quantitative Flow Characterization Using 2D and 4D Flow MRI
| NCT ID | NCT06888024 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ningcheng Peter Li |
| Condition | May-Thurner Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 15 participants |
| Start Date | 2025-04-01 |
| Primary Completion | 2027-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 15 participants in total. It began in 2025-04-01 with a primary completion date of 2027-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the study is to quantitatively characterize the flow in the pelvic venous structures using 2D and 4D flow MRI with the objective of establishing physiologic and pathologic parameters for downstream computational fluid dynamics analysis. Arm 1: To establish the baseline flow characteristics of the iliac veins in patients with no imaging evidence of iliac venous disease. Arm 2: To assess the flow characteristics of the iliac veins in patients with left iliac vein compression syndrome (a.k.a. May-Thurner syndrome). Arm 3: To assess the flow characteristics of the iliac veins in patients status post iliac stent placement.
Eligibility Criteria
Arm 1: Inclusion Criteria: • No self-reported history of pelvic or iliac venous disease or associated symptoms Exclusion Criteria: * History of pelvic or iliac venous disease or intervention * Contraindication to MRI examination * Prisoners * Subjects ≤ 18 years of age * Pregnant women * Adults unable to provide informed consent Arm 2: Inclusion Criteria: • Clinical symptoms or imaging findings compatible with left iliac vein compression syndrome Exclusion Criteria: * History of pelvic or iliac venous intervention * Contraindication to MRI examination * Prisoners * Subjects ≤ 18 years of age * Pregnant women * Adults unable to provide informed consent Arm 3: Inclusion Criteria: • History of left iliac vein stent placement Exclusion Criteria: * Contraindication to MRI examination * Prisoners * Subjects ≤ 18 years of age * Pregnant women * Adults unable to provide informed consent
Contact & Investigator
Ningcheng Li, MD
PRINCIPAL INVESTIGATOR
UMass Chan Medical School
Frequently Asked Questions
Who can join the NCT06888024 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 89 Years, studying May-Thurner Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06888024 currently recruiting?
Yes, NCT06888024 is actively recruiting participants. Contact the research team at noelle.bodkin@umassmed.edu for enrollment information.
Where is the NCT06888024 trial being conducted?
This trial is being conducted at Worcester, United States.
Who is sponsoring the NCT06888024 clinical trial?
NCT06888024 is sponsored by Ningcheng Peter Li. The principal investigator is Ningcheng Li, MD at UMass Chan Medical School. The trial plans to enroll 15 participants.